# Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia

> **NCT04948463** · PHASE4 · COMPLETED · sponsor: **Murdoch Childrens Research Institute** · enrollment: 55 (actual)

## Conditions studied

- Febrile Neutropenia

## Interventions

- **DRUG:** Piperacillin and Tazobactam for Injection
- **DRUG:** Cefepime Injection
- **DRUG:** Ceftazidime Injection
- **DRUG:** Vancomycin Injection
- **DRUG:** Amikacin Injection
- **DRUG:** Ciprofloxacin
- **DRUG:** Piperacillin and Tazobactam for Injection
- **DRUG:** Cefepime Injection
- **DRUG:** Ceftazidime Injection
- **DRUG:** Vancomycin Injection
- **DRUG:** Amikacin Injection
- **DRUG:** Ciprofloxacin

## Key facts

- **NCT ID:** NCT04948463
- **Lead sponsor:** Murdoch Childrens Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-15
- **Primary completion:** 2025-12-17
- **Final completion:** 2025-12-17
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04948463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04948463, "Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04948463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*